Jpmorgan Chase & CO Retractable Technologies Inc Transaction History
Jpmorgan Chase & CO
- $1.51 Trillion
- Q3 2025
A detailed history of Jpmorgan Chase & CO transactions in Retractable Technologies Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 295 shares of RVP stock, worth $230. This represents 0.0% of its overall portfolio holdings.
Number of Shares
295
Previous 295
-0.0%
Holding current value
$230
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RVP
# of Institutions
33Shares Held
2.5MCall Options Held
11.9KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA673KShares$524,7910.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny428KShares$333,4990.0% of portfolio
-
Eversept Partners, LP New York, NY363KShares$283,3850.02% of portfolio
-
Black Rock Inc. New York, NY274KShares$213,7010.0% of portfolio
-
Geode Capital Management, LLC Boston, MA128KShares$99,9230.0% of portfolio
About RETRACTABLE TECHNOLOGIES INC
- Ticker RVP
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 32,937,200
- Market Cap $25.7M
- Description
- Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adap...